ArticleFrontiers in immunology2026

Metformin use and the risk of incident immune-mediated diseases in patients with type 2 diabetes: a population-based cohort study.

Qianru Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.